Skip to main content
PMC home page
The BMJ logoLink to The BMJ
. 1994 Apr 9;308(6934):957–961. doi: 10.1136/bmj.308.6934.957

Impotence: diagnosis and management of male erectile dysfunction.

R S Kirby 1
PMCID: PMC2539778  PMID: 8173405

Full text

PDF
960

Images in this article

958FIG 2
on p.958
959FIG 3
on p.959

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bancroft J., Wu F. C. Changes in erectile responsiveness during androgen replacement therapy. Arch Sex Behav. 1983 Feb;12(1):59–66. doi: 10.1007/BF01542116. [DOI] [PubMed] [Google Scholar]
  2. Bookstein J. J., Valji K., Parsons L., Kessler W. Pharmacoarteriography in the evaluation of impotence. J Urol. 1987 Feb;137(2):333–337. doi: 10.1016/s0022-5347(17)44017-1. [DOI] [PubMed] [Google Scholar]
  3. Brindley G. S. Pilot experiments on the actions of drugs injected into the human corpus cavernosum penis. Br J Pharmacol. 1986 Mar;87(3):495–500. doi: 10.1111/j.1476-5381.1986.tb10191.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Djamilian M., Stief C. G., Kuczyk M., Jonas U. Followup results of a combination of calcitonin gene-related peptide and prostaglandin E1 in the treatment of erectile dysfunction. J Urol. 1993 May;149(5 Pt 2):1296–1298. doi: 10.1016/s0022-5347(17)36372-3. [DOI] [PubMed] [Google Scholar]
  5. Ek A., Bradley W. E., Krane R. J. Nocturnal penile rigidity measured by the snap-gauge band. J Urol. 1983 May;129(5):964–966. doi: 10.1016/s0022-5347(17)52486-6. [DOI] [PubMed] [Google Scholar]
  6. Franks S., Jacobs H. S., Martin N., Nabarro J. D. Hyperprolactinaemia and impotence. Clin Endocrinol (Oxf) 1978 Apr;8(4):277–287. doi: 10.1111/j.1365-2265.1978.tb02770.x. [DOI] [PubMed] [Google Scholar]
  7. Goldstein I. Arterial revascularization procedures. Semin Urol. 1986 Nov;4(4):252–258. [PubMed] [Google Scholar]
  8. Hollander J. B., Gonzalez J., Norman T. Patient satisfaction with pharmacologic erection program. Urology. 1992 May;39(5):439–441. doi: 10.1016/0090-4295(92)90242-o. [DOI] [PubMed] [Google Scholar]
  9. Krane R. J., Goldstein I., Saenz de Tejada I. Impotence. N Engl J Med. 1989 Dec 14;321(24):1648–1659. doi: 10.1056/NEJM198912143212406. [DOI] [PubMed] [Google Scholar]
  10. Lerner S. E., Melman A., Christ G. J. A review of erectile dysfunction: new insights and more questions. J Urol. 1993 May;149(5 Pt 2):1246–1255. doi: 10.1016/s0022-5347(17)36359-0. [DOI] [PubMed] [Google Scholar]
  11. Lue T. F., Hricak H., Marich K. W., Tanagho E. A. Vasculogenic impotence evaluated by high-resolution ultrasonography and pulsed Doppler spectrum analysis. Radiology. 1985 Jun;155(3):777–781. doi: 10.1148/radiology.155.3.3890009. [DOI] [PubMed] [Google Scholar]
  12. Lue T. F., Tanagho E. A. Physiology of erection and pharmacological management of impotence. J Urol. 1987 May;137(5):829–836. doi: 10.1016/s0022-5347(17)44267-4. [DOI] [PubMed] [Google Scholar]
  13. Malloy T. R., Wein A. J., Carpiniello V. L. Reliability of AMS M700 inflatable penile prosthesis. Urology. 1986 Nov;28(5):385–387. doi: 10.1016/0090-4295(86)90067-1. [DOI] [PubMed] [Google Scholar]
  14. McCulloch D. K., Campbell I. W., Wu F. C., Prescott R. J., Clarke B. F. The prevalence of diabetic impotence. Diabetologia. 1980 Apr;18(4):279–283. doi: 10.1007/BF00251005. [DOI] [PubMed] [Google Scholar]
  15. Michal V. Arterial disease as a cause of impotence. Clin Endocrinol Metab. 1982 Nov;11(3):725–748. doi: 10.1016/s0300-595x(82)80010-8. [DOI] [PubMed] [Google Scholar]
  16. Reid K., Surridge D. H., Morales A., Condra M., Harris C., Owen J., Fenemore J. Double-blind trial of yohimbine in treatment of psychogenic impotence. Lancet. 1987 Aug 22;2(8556):421–423. doi: 10.1016/s0140-6736(87)90958-5. [DOI] [PubMed] [Google Scholar]
  17. Stackl W., Hasun R., Marberger M. Intracavernous injection of prostaglandin E1 in impotent men. J Urol. 1988 Jul;140(1):66–68. doi: 10.1016/s0022-5347(17)41488-1. [DOI] [PubMed] [Google Scholar]
  18. Susset J. G., Tessier C. D., Wincze J., Bansal S., Malhotra C., Schwacha M. G. Effect of yohimbine hydrochloride on erectile impotence: a double-blind study. J Urol. 1989 Jun;141(6):1360–1363. doi: 10.1016/s0022-5347(17)41308-5. [DOI] [PubMed] [Google Scholar]
  19. Troy K., Cuttner J., Reilly M., Grabowski G., Desnick R. Tartrate-resistant acid phosphatase staining of monocytes in Gaucher disease. Am J Hematol. 1985 Jul;19(3):237–244. doi: 10.1002/ajh.2830190305. [DOI] [PubMed] [Google Scholar]
  20. Virag R. Intracavernous injection of papaverine for erectile failure. Lancet. 1982 Oct 23;2(8304):938–938. doi: 10.1016/s0140-6736(82)90910-2. [DOI] [PubMed] [Google Scholar]
  21. Wilson J. D., Griffin J. E. The use and misuse of androgens. Metabolism. 1980 Dec;29(12):1278–1295. doi: 10.1016/0026-0495(80)90159-6. [DOI] [PubMed] [Google Scholar]
  22. Wilson S. K., Wahman G. E., Lange J. L. Eleven years of experience with the inflatable penile prosthesis. J Urol. 1988 May;139(5):951–952. doi: 10.1016/s0022-5347(17)42726-1. [DOI] [PubMed] [Google Scholar]
  23. Witherington R. Vacuum constriction device for management of erectile impotence. J Urol. 1989 Feb;141(2):320–322. doi: 10.1016/s0022-5347(17)40752-x. [DOI] [PubMed] [Google Scholar]
  24. von Heyden B., Donatucci C. F., Kaula N., Lue T. F. Intracavernous pharmacotherapy for impotence: selection of appropriate agent and dose. J Urol. 1993 May;149(5 Pt 2):1288–1290. doi: 10.1016/s0022-5347(17)36370-x. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES